China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
China Resources Pharmaceutical Group Ltd. has announced a plan to increase its shareholding in Jiangzhong Pharmaceutical, targeting an investment between RMB60 million and RMB120 million. This move, aimed at boosting investor confidence and recognizing the long-term value of Jiangzhong, will be executed within the next 12 months through the Shanghai Stock Exchange. The decision underscores the Group’s confidence in Jiangzhong’s future growth prospects.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
